ctrl K

Watchlist Price Alert

Tourmaline Bio Inc. (TRML)

NASDAQ: TRML · Real-Time Price · USD

18.41

-0.56 (-2.95%)

At close: Jun 17, 2025, 3:33 PM

Tourmaline Bio Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	n/a	n/a	n/a	n/a	n/a	n/a
Cost of Revenue	n/a	33K	6K	623K	447K	379K
Gross Profit	n/a	-33K	-6K	-623K	-447K	-379K
Operating Income	-89.73M	-45.41M	-19.7M	-904	-22.68M	-18.38M
Interest Income	n/a	n/a	n/a	n/a	n/a	223K
Pretax Income	-73.21M	-42.12M	-19.7M	-904	-22.71M	-18.16M
Net Income	-73.21M	-42.12M	-19.7M	-904	-22.71M	-18.16M
Selling & General & Admin	22.75M	13.04M	2.17M	692.00	6.96M	4.63M
Research & Development	66.98M	32.37M	17.53M	212.00	15.28M	13.37M
Other Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Operating Expenses	89.73M	45.41M	19.7M	904.00	22.24M	18M
Interest Expense	n/a	n/a	n/a	n/a	23K	n/a
Selling & Marketing Expenses	n/a	n/a	n/a	n/a	n/a	n/a
Cost & Expenses	n/a	45.41M	19.7M	904.00	22.68M	18.38M
Income Tax Expense	n/a	n/a	n/a	-47.21M	n/a	n/a
Shares Outstanding (Basic)	25.35M	4.75M	20.34M	10.88M	668.51K	4.13M
Shares Outstanding (Diluted)	25.35M	4.75M	20.34M	10.88M	668.51K	4.13M
EPS (Basic)	-2.89	-8.87	-0.97	-0.00	-33.97	-4.39
EPS (Diluted)	-2.89	-8.87	-0.97	-0.00	-33.97	-4.39
EBITDA	-89.73M	-45.38M	-19.7M	-46.88M	-22.24M	-17.78M
EBIT	-73.21M	-42.12M	-19.7M	-47.51M	-22.68M	-18.16M
Depreciation & Amortization	-16.52M	33K	6K	904.00	447K	379K